Nishimoto N - Search Results

1

Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus.

Lee HM, Mima T, Sugino H, Aoki C, Adachi Y, Yoshio-Hoshino N, Matsubara K, Nishimoto N. Lee HM, et al. Among authors: nishimoto n. Arthritis Res Ther. 2009;11(1):R1. doi: 10.1186/ar2584. Epub 2009 Jan 3. Arthritis Res Ther. 2009. PMID: 19121222 Free PMC article.

2

Cytokine networks in systemic lupus erythematosus.

Lee HM, Sugino H, Nishimoto N. Lee HM, et al. Among authors: nishimoto n. J Biomed Biotechnol. 2010;2010:676284. doi: 10.1155/2010/676284. Epub 2010 Apr 15. J Biomed Biotechnol. 2010. PMID: 20414360 Free PMC article. Review.

3

Underexpression of mitochondrial-DNA encoded ATP synthesis-related genes and DNA repair genes in systemic lupus erythematosus.

Lee HM, Sugino H, Aoki C, Nishimoto N. Lee HM, et al. Among authors: nishimoto n. Arthritis Res Ther. 2011 Apr 15;13(2):R63. doi: 10.1186/ar3317. Arthritis Res Ther. 2011. PMID: 21496236 Free PMC article.

4

Abnormal networks of immune response-related molecules in bone marrow cells from patients with rheumatoid arthritis as revealed by DNA microarray analysis.

Lee HM, Sugino H, Aoki C, Shimaoka Y, Suzuki R, Ochi K, Ochi T, Nishimoto N. Lee HM, et al. Among authors: nishimoto n. Arthritis Res Ther. 2011 Jun 16;13(3):R89. doi: 10.1186/ar3364. Arthritis Res Ther. 2011. PMID: 21679443 Free PMC article.

5

Establishment of a new interleukin-6 (IL-6) receptor inhibitor applicable to the gene therapy for IL-6-dependent tumor.

Yoshio-Hoshino N, Adachi Y, Aoki C, Pereboev A, Curiel DT, Nishimoto N. Yoshio-Hoshino N, et al. Among authors: nishimoto n. Cancer Res. 2007 Feb 1;67(3):871-5. doi: 10.1158/0008-5472.CAN-06-3641. Cancer Res. 2007. PMID: 17283116

6

Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody.

Nishimoto N, Nakahara H, Yoshio-Hoshino N, Mima T. Nishimoto N, et al. Arthritis Rheum. 2008 Apr;58(4):1197-200. doi: 10.1002/art.23373. Arthritis Rheum. 2008. PMID: 18383395 Free article.

7

The blockade of IL-6 signaling in rational drug design.

Adachi Y, Yoshio-Hoshino N, Nishimoto N. Adachi Y, et al. Among authors: nishimoto n. Curr Pharm Des. 2008;14(12):1217-24. doi: 10.2174/138161208784246072. Curr Pharm Des. 2008. PMID: 18473869 Review.

8

Gene therapy for multiple myeloma.

Adachi Y, Yoshio-Hoshino N, Nishimoto N. Adachi Y, et al. Among authors: nishimoto n. Curr Gene Ther. 2008 Aug;8(4):247-55. doi: 10.2174/156652308785160683. Curr Gene Ther. 2008. PMID: 18691020 Review.

9

Clinical value of blocking IL-6 receptor.

Mima T, Nishimoto N. Mima T, et al. Among authors: nishimoto n. Curr Opin Rheumatol. 2009 May;21(3):224-30. doi: 10.1097/BOR.0b013e3283295fec. Curr Opin Rheumatol. 2009. PMID: 19365268 Review.

10

DNA microarray analysis of rheumatoid arthritis susceptibility genes identified by genome-wide association studies.

Sugino H, Lee HM, Nishimoto N. Sugino H, et al. Among authors: nishimoto n. Arthritis Res Ther. 2010;12(2):401. doi: 10.1186/ar2937. Epub 2010 Mar 12. Arthritis Res Ther. 2010. PMID: 20346099 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

361 results

Search Page

Filters